HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions. (December 2018)
- Record Type:
- Journal Article
- Title:
- HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions. (December 2018)
- Main Title:
- HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions
- Authors:
- Zummeren, Marjolein
Kremer, Wieke
Leeman, Annemiek
Bleeker, Maaike
Jenkins, David
Sandt, Miekel
Doorbar, John
Heideman, Daniëlle
Steenbergen, Renske
Snijders, Peter
Kenter, Gemma
Quint, Wim
Berkhof, Johannes
Meijer, Chris - Abstract:
- Abstract In this study, we evaluate the expression of human papillomavirus E4 protein (marker for the onset of a productive infection) and hypermethylation of host-cellCADM1, MAL, andmiR124-2 genes (marker for an advanced, transforming infection) in cervical intraepithelial neoplasia (CIN) and cancer. A total of 115 cervical lesions were categorized by 3 pathologists into no dysplasia, CIN1, CIN2, CIN3, or cancer by classical histomorphological grading criteria, and by an immunoscore (cumulative value: 0–6) grading system based on Ki-67 (score: 0–3) and p16ink4a (score: 0–3) expression. Lesions were immunostained for E4 protein and analyzed for hypermethylation ofCADM1, MAL, ormiR124-2 genes. Expression of E4 and hypermethylation levels were related to CIN grade based on both classical and immunoscore grading. Hypermethylation increased with severity of the lesion as defined by both classical histomorphological grading and immunoscore criteria, and was always present in carcinomas (22/22). Extensive E4 expression decreased with increasing CIN grade and immunoscore, being most frequent in classically graded CIN1 or in lesions with cumulative immunoscore 1–3 and absent in carcinomas. High-grade lesions (CIN2/3 or immunoscore: 4–6) showed less E4 expression, which was inversely related to an increasing hypermethylation. Extensive E4 expression, as observed in a small proportion of high-grade lesions (6/49 and 8/43, respectively), was mostly associated with a negativeAbstract In this study, we evaluate the expression of human papillomavirus E4 protein (marker for the onset of a productive infection) and hypermethylation of host-cellCADM1, MAL, andmiR124-2 genes (marker for an advanced, transforming infection) in cervical intraepithelial neoplasia (CIN) and cancer. A total of 115 cervical lesions were categorized by 3 pathologists into no dysplasia, CIN1, CIN2, CIN3, or cancer by classical histomorphological grading criteria, and by an immunoscore (cumulative value: 0–6) grading system based on Ki-67 (score: 0–3) and p16ink4a (score: 0–3) expression. Lesions were immunostained for E4 protein and analyzed for hypermethylation ofCADM1, MAL, ormiR124-2 genes. Expression of E4 and hypermethylation levels were related to CIN grade based on both classical and immunoscore grading. Hypermethylation increased with severity of the lesion as defined by both classical histomorphological grading and immunoscore criteria, and was always present in carcinomas (22/22). Extensive E4 expression decreased with increasing CIN grade and immunoscore, being most frequent in classically graded CIN1 or in lesions with cumulative immunoscore 1–3 and absent in carcinomas. High-grade lesions (CIN2/3 or immunoscore: 4–6) showed less E4 expression, which was inversely related to an increasing hypermethylation. Extensive E4 expression, as observed in a small proportion of high-grade lesions (6/49 and 8/43, respectively), was mostly associated with a negative methylation marker status (5/6 and 7/8, respectively). Our results illustrate the gradual transition of productive CIN (reflected by extensive E4 expression), to advanced transforming CIN (reflected by extensive hypermethylation) and cancer. Expression patterns of E4 and hypermethylation status of host-cell genes, may be used to identify cervical lesions at risk for cervical cancer, providing a better guidance for clinicians on treatment decisions. … (more)
- Is Part Of:
- Modern pathology. Volume 31:Number 12(2018)
- Journal:
- Modern pathology
- Issue:
- Volume 31:Number 12(2018)
- Issue Display:
- Volume 31, Issue 12 (2018)
- Year:
- 2018
- Volume:
- 31
- Issue:
- 12
- Issue Sort Value:
- 2018-0031-0012-0000
- Page Start:
- 1842
- Page End:
- 1850
- Publication Date:
- 2018-12
- Subjects:
- Pathology -- Periodicals
Diagnosis, Laboratory -- Periodicals
Pathologie -- Périodiques
Diagnostics biologiques -- Périodiques
Diagnosis, Laboratory
Pathology
Pathology -- Abstracts
Pathology -- Periodicals
Periodicals
Electronic journals
616.07 - Journal URLs:
- http://www.nature.com/modpathol/index.html ↗
http://modpath.uscapjournals.org/ ↗
http://www.nature.com/ ↗ - DOI:
- 10.1038/s41379-018-0101-z ↗
- Languages:
- English
- ISSNs:
- 0893-3952
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5890.767000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11173.xml